ACRV Stock Analysis: Buy, Sell, or Hold?
ACRV - Acrivon Therapeutics, Inc. Common Stock
$1.75
0.00 (0.00%)
▲
5d:
-10.71%
30d:
+17.45%
90d:
+4.79%
HOLD
MODERATE Confidence
Analysis Updated: Jul 17, 2026 12:00 AM ET
Earnings: Aug 12, 2026
25d
Get Alerted When ACRV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ACRV shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: ACRV shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: ACRV is currently trading at $1.75, which is considered extended relative to its 30-day fair value range of $1.46 to $1.89.
Technical Outlook: Technically, ACRV is in a uptrend. Immediate support is located at $1.69, while resistance sits at $2.15.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $11.50 (+557.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ACRV is in a uptrend. Immediate support is located at $1.69, while resistance sits at $2.15.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $11.50 (+557.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.46 -
$1.89
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
51.1%
All Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 557.1% below Wall St target ($11.50)
- CAUTION: 5-day price weakness (-10.7%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$1.46 -
$1.89
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$1.69
Resistance Level
$2.16
Current Trend
Uptrend
Technical data as of
Jul 17, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.90
Wall Street Target
$11.50
(+557.1%)
Share & Embed Analysis
Last updated: July 17, 2026 3:37 PM ET
Data refreshes hourly during market hours. Next update: 4:37 PM
Data refreshes hourly during market hours. Next update: 4:37 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ACRV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$441 | 45 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 60 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 56 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$297 | 54 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 59 HOLD |
